During the past decade, Prisma Health, Institute for Translational Oncology Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prisma Health, Institute for Translational Oncology Research" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator and "ICON plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Prisma Health, Institute for Translational Oncology Research" are "Acute Myelogenous Leukemia" (1 trials), "Acute Myelogenous Leukemia in Relapse" (1 trials), "Acute Myelogenous Leukemia, Adult" (1 trials), "Acute Myelogenous Leukemia, Relapsed, Adult" (1 trials) and "Advanced Lymphoma" (1 trials). Many other conditions were trialed in "Prisma Health, Institute for Translational Oncology Research" in a lesser frequency.

Most popular intervention types in "Prisma Health, Institute for Translational Oncology Research" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AN4005-dose level 0" (1 trials), "AN4005-dose level 1" (1 trials), "AN4005-dose level 2" (1 trials), "AN4005-dose level 3" (1 trials) and "AN4005-dose level 4" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prisma Health, Institute for Translational Oncology Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Prisma Health, Institute for Translational Oncology Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Prisma Health, Institute for Translational Oncology Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Prisma Health, Institute for Translational Oncology Research, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".